FDA approves pill version of popular weight loss injection
Clinical trial data show an average weight loss of about 13.6% of body weight, close to the results seen with injections. The pill must be taken in the morning on an empty stomach, with no eating for 30 minutes afterward, a requirement that could make long-term adherence more difficult. The pill will be sold in the US for $149 per month and is expected to reach Israel only later in the year or in 2027.





!['Long-term infections allow the virus to explore ways to infect cells more efficiently, and [this study] adds to the evidence that more transmissible variants have emerged from such infections,' Harvard University epidemiologist William Hanage says. Researchers discover Israeli coronavirus variant, but risk low](https://www.israelhayom.com/wp-content/uploads/2021/03/GettyImages-1209688759-350x250.jpg)



